FDA alert on clopidogrel PPI
Links shared publicly online about this topic.
- 1,595total visits
FDA alert on clopidogrel PPI
View full resource at theheart.org
Tags: GERD Medication, Zollinger-Ellison Syndrome Medication, FDA, Anti-Clotting Medication, Plavix, Iscover, Cardiologist, Cardiology
Most Recently Shared on November 17, 2009 at 9:25 pm By:
Cardiologists shocked by new FDA alert on clopidogrel-PPI interaction http://bit.ly/1c8h4X #SS09 #aha09
FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs)
fda.gov — “[3-2-2011] The U.S. Food and Drug Administration (FDA) is informing the public that prescription proton pump inhibitor (PPI) drugs may cause low serum magnesium levels (hypomagnesemia) if taken for prolonged periods of time (in most cases, longer than one year).” View full resource at fda.gov
Most Recently Shared on March 9, 2011 at 1:16 pm By:
FDA Alert: Proton Pump Inhibitors and Low Magnesium levels http://1.usa.gov/g8rGb9
Long-Term Use of Proton-Pump Inhibitors May Lower Magnesium Levels - Physician's First Watch
firstwatch.jwatch.org — “Using a proton-pump inhibitor for extended periods may cause low serum magnesium levels, the FDA cautioned yesterday. The agency issued the alert after reviewing more than 50 cases of hypomagnesemia in patients taking PPIs over . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on March 5, 2011 at 3:05 am By:
Lionel Lim Internist, Geriatrician, Physician, and Doctor
Long-Term PPI use Lowers Magnesium Levels - over long periods, usually a year or more. http://icio.us/U7X9ab
Clopidogrel-PPI: Mechanistic studies | theheart.org theheart.org: Interventional and Surgery news and education
theheart.org — “Heartwire staff and renowned specialists in cardiology from Duke Clinical Research Institute and Mayo Clinic discuss latest developments in interventional surgery.” View full resource at theheart.org
Most Recently Shared on September 20, 2010 at 5:20 pm By:
Clopidogrel-PPI interaction: Mechanistic studies that led to FDA warning now published: But cardiologists continue... http://bit.ly/dsteR1
ACC and AHA on clopidogrel label | theheart.org
theheart.org — “The ACC and AHA issued a clinical alert just 12 weeks after the FDA black-box warning on clopidogrel, stating that routine genetic or platelet-function testing is not recommended when using antiplatelet therapy. They do leave the door open a crack, however, and allow for such testing in patients believed to be at moderate or high risk for poor outcomes, to be used at the physician's discretion.” View full resource at theheart.org
Most Recently Shared on June 30, 2010 at 5:50 pm By:
No routine genetic or platelet-function testing for clopidogrel nonresponsiveness: ACC, AHA: The ACC and AHA issue... http://bit.ly/d8ujUf
FDA Alert: Proton Pump Inhibitors (PPI): Class Labeling Change
drugs.com — “FDA Alert: Proton Pump Inhibitors (PPI): Class Labeling Change” View full resource at drugs.com
Most Recently Shared on May 28, 2010 at 8:55 am By:
FDA Alert - Labeling Change for Proton Pump Inhibitors - http://bit.ly/cmqvjA
FDA Announces New Boxed Warning On Plavix
medicalnewstoday.com — “The U.S. Food and Drug Administration added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effectiv” View full resource at medicalnewstoday.com
Most Recently Shared on March 15, 2010 at 2:06 pm By:
MNT Cardiovascular Health News
FDA Announces New Boxed Warning On Plavix http://mnt.to/3yVm #cardiovascular
FDA warns patients and physicians about the efficacy of Plavix treatment
news-medical.net — “The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.” View full resource at news-medical.net
Most Recently Shared on March 15, 2010 at 4:57 am By:
FDA warns patients and physicians about the efficacy of Plavix treatment: The U.S. Food and Drug Administration to... http://bit.ly/byC3Vt
FDA Alert: Plavix (clopidogrel): Reduced effectiveness in patients who are poor metabolizers of the drug
drugs.com — “FDA Alert: Plavix (clopidogrel): Reduced effectiveness in patients who are poor metabolizers of the drug” View full resource at drugs.com
Most Recently Shared on March 14, 2010 at 12:55 am By:
RT @drugscom FDA Alert: Plavix (clopidogrel): Reduced effectiveness in patients who are poor metabol.. http://is.gd/aoMTl
FDA Announces New Boxed Warning on Plavix - Drugs.com MedNews
drugs.com — “The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care profes” View full resource at drugs.com
Most Recently Shared on March 13, 2010 at 5:54 am By:
FDA Announces New Boxed Warning on Plavix - http://bit.ly/cU7CJJ
FDA Announces New Boxed Warning on Plavix
fda.gov — “The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.” View full resource at fda.gov
Most Recently Shared on March 12, 2010 at 7:28 pm By:
FDA's Bob Temple on new Plavix boxed warning: ''There's more uncertainty than I wish we had about what 2 do." http://bit.ly/asICPn #genetics
FDA Alert: Clopidogrel (marketed as Plavix) and Omeprazole (marketed as Prilosec) - Drug Interaction
drugs.com — “FDA Alert: Clopidogrel (marketed as Plavix) and Omeprazole (marketed as Prilosec) - Drug Interaction” View full resource at drugs.com
Most Recently Shared on November 19, 2009 at 8:51 am By:
FDA Alert - FDA Warns of Drug Interactions between Plavix and Prilosec - http://bit.ly/37OHXz
FDA warns of drug interaction with clopidogrel and omeprazole - MPR
empr.com — “The FDA has notified healthcare professionals of new safety information concerning a drug interaction between clopidogrel bisulfate (Plavix, from Bristol-Myers Squibb and sanofi-aventis), a platelet aggregation inhibitor, and omeprazole (Prilosec, from AstraZeneca; and Prilosec OTC, from Procter & Gamble), a proton pump inhibitor (PPI).” View full resource at empr.com
Most Recently Shared on November 17, 2009 at 6:23 pm By:
MPR News: FDA warns of drug interaction with clopidogrel and omeprazole: The FDA has notified healthcare profession... http://bit.ly/3MR012
Medical News: FDA Approves New Antiplatelet for Angioplasty Patients - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the oral antiplatelet agent prasugrel (Effient), putting it in top running as a direct competitor for clopidogrel (Plavix).” View full resource at medpagetoday.com
Most Recently Shared on July 10, 2009 at 11:31 pm By:
CARDIOLOGY• FDA Approves New Antiplatelet for Angioplasty Patients http://tinyurl.com/n4s9yg
Clopidogrel-PPI interaction?
theheart.org — “The European Medicines Agency has now followed suit with the US FDA and issued a warning discouraging concomitant use of clopidogrel and PPIs, but some experts believe the issue has been overhyped.” View full resource at theheart.org
Most Recently Shared on June 19, 2009 at 6:26 pm By:
heartwire: EMEA issues warning on possible clopidogrel-PPI interaction, but is there really a problem? http://bit.ly/b9M2n
Advertisement
